Re-infection following sustained virological response with a different hepatitis C virus genotype: implications for infection control policy.
Clin Kidney J
; 5(3): 250-3, 2012 Jun.
Article
en En
| MEDLINE
| ID: mdl-26069778
ABSTRACT
We report the case of a 45-year-old haemodialysis patient who achieved a sustained virological response (SVR) following pegylated interferon therapy for hepatitis C virus (HCV) genotype 2 infection. He was subsequently cohorted with other HCV-infected dialysis patients and became re-infected with HCV genotype 3a. Epidemiological and molecular investigations identified a highly viraemic HCV genotype 3a-infected dialysis patient as the likely source of this infection. This critical incident informed a revision to local and national infection control policy regarding the dialysis management of patients who achieve an SVR following anti-viral treatment.
Texto completo:
1
Colección:
01-internacional
Banco de datos:
MEDLINE
Tipo de estudio:
Prognostic_studies
Idioma:
En
Revista:
Clin Kidney J
Año:
2012
Tipo del documento:
Article
País de afiliación:
Irlanda